Sen. Brown, Bipartisan Group of Colleagues Call on Drug Manufacturers to Make Naloxone Available Over Counter
April 13, 2022
April 13, 2022
WASHINGTON, April 13 -- Sen. Sherrod Brown, D-Ohio, issued the following news release:
U.S. Senator Sherrod Brown (D-OH) joined U.S. Senators Tammy Baldwin (D-WI), Maggie Hassan (D-NH) and Angus King (I-ME) and U.S. Representatives Carolyn B. Maloney (D-NY) and Brian Fitzpatrick (R-PA), along with a bicameral, bipartisan group of colleagues in sending letters to seven major manufacturers of naloxone, the opioid overdose reversal medication, urging them to apply for over the counter . . .
U.S. Senator Sherrod Brown (D-OH) joined U.S. Senators Tammy Baldwin (D-WI), Maggie Hassan (D-NH) and Angus King (I-ME) and U.S. Representatives Carolyn B. Maloney (D-NY) and Brian Fitzpatrick (R-PA), along with a bicameral, bipartisan group of colleagues in sending letters to seven major manufacturers of naloxone, the opioid overdose reversal medication, urging them to apply for over the counter . . .